Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
1.
Actas dermo-sifiliogr. (Ed. impr.) ; 108(6): e45-e48, jul.-ago. 2017. ilus
Artículo en Español | IBECS | ID: ibc-164514

RESUMEN

La terapia fotodinámica tiene una importante acción antimicrobiana. Se presentan 2 casos clínicos de úlceras crónicas en las extremidades inferiores sobreinfectadas por hongos y bacterias de difícil manejo, en los que el tratamiento fotodinámico con azul de metileno como fotosensibilizante resultó en la curación clínica y microbiológica. No se presentaron efectos adversos reseñables. La posibilidad de utilizar la terapia fotodinámica con azul de metileno en el manejo de las úlceras crónicas sobreinfectadas constituye una interesante alternativa para reducir el uso de antibióticos y disminuir la aparición de resistencias (AU)


Photodynamic therapy (PDT) is a therapeutic modality with significant antimicrobial activity. We present 2 cases of chronic lower limb ulcers in which fungal and bacterial superinfection complicated management. PDT with methylene blue as the photosensitizer led to clinical and microbiological cure with no significant adverse effects. PDT with methylene blue is a valid option for the management of superinfected chronic ulcers, reducing the use of antibiotics and the induction of resistance (AU)


Asunto(s)
Humanos , Femenino , Adulto , Anciano , Azul de Metileno/uso terapéutico , Fototerapia , Úlcera Cutánea/terapia , Infección de Heridas/terapia , Infecciones por Pseudomonas/terapia , Dermatomicosis/terapia , Úlcera de la Pierna/terapia , Antibacterianos/uso terapéutico , Antifúngicos/uso terapéutico , Pseudomonas aeruginosa/aislamiento & purificación , Fusarium/aislamiento & purificación
2.
Actas Dermosifiliogr ; 108(6): e45-e48, 2017.
Artículo en Inglés, Español | MEDLINE | ID: mdl-28411862

RESUMEN

Photodynamic therapy (PDT) is a therapeutic modality with significant antimicrobial activity. We present 2 cases of chronic lower limb ulcers in which fungal and bacterial superinfection complicated management. PDT with methylene blue as the photosensitizer led to clinical and microbiological cure with no significant adverse effects. PDT with methylene blue is a valid option for the management of superinfected chronic ulcers, reducing the use of antibiotics and the induction of resistance.


Asunto(s)
Fusariosis/tratamiento farmacológico , Fusarium/efectos de los fármacos , Úlcera de la Pierna/microbiología , Azul de Metileno/uso terapéutico , Micosis/tratamiento farmacológico , Fotoquimioterapia , Fármacos Fotosensibilizantes/uso terapéutico , Infecciones por Pseudomonas/tratamiento farmacológico , Pseudomonas aeruginosa/efectos de los fármacos , Sobreinfección/tratamiento farmacológico , Adulto , Anciano , Quemaduras por Electricidad/complicaciones , Quemaduras por Electricidad/microbiología , Enfermedad Crónica , Femenino , Fusariosis/etiología , Humanos , Huésped Inmunocomprometido , Complicaciones Intraoperatorias , Úlcera de la Pierna/complicaciones , Micosis/etiología , Infecciones por Pseudomonas/etiología , Sobreinfección/etiología , Cicatrización de Heridas , Infección de Heridas/tratamiento farmacológico , Infección de Heridas/microbiología
3.
Rev. clín. esp. (Ed. impr.) ; 217(1): 15-20, ene.-feb. 2017. tab, graf
Artículo en Español | IBECS | ID: ibc-159525

RESUMEN

Objetivo. Describir las características de las bacteriemias, según la edad, en un hospital comunitario. Material y método. Estudio prospectivo de las bacteriemias en el año 2011. Los pacientes se clasificaron en 3 grupos de edad: menos de 65, de 65 a 79 y 80 o más años. Se recogieron variables de los pacientes y de los episodios. Resultados. Se analizaron 233 bacteriemias en 227 pacientes (23,8% en<65; 38,3% entre 65 y 79; y 37,9% en≥80 años). La enfermedad de base más frecuente en todos los grupos fue la diabetes mellitus. En los pacientes muy ancianos el índice de Charlson fue mayor, hubo una menor proporción de factores exógenos y casi un 25% eran dependientes graves (índice de Barthel<20). Escherichia coli fue el germen más frecuente y el foco principal fue el urológico. En los pacientes≥80 años predominó el origen de la infección asociado a cuidados sanitarios, la expresividad clínica menos grave (sepsis) (66,3%) y la mortalidad más elevada (29,1%), respecto a los de menor edad. Conclusiones. Los pacientes muy ancianos con bacteriemia presentaron menos factores exógenos, más comorbilidad y una situación funcional peor; el foco más frecuente fue el urológico y el origen el asociado a cuidados sanitarios. A pesar de que su presentación clínica fue menos grave, su mortalidad fue superior, siendo el grado de dependencia una variable de riesgo independiente muy relevante (AU)


Objective. To describe the characteristics of bacteraemias, according to age, in a community hospital. Material and method. A prospective study of bacteraemias was conducted in 2011. The patients were classified into 3 age groups: younger than 65 years, 65 to 79, and 80 or older. The study collected variables on the patients and episodes. Results. The study analysed 233 bacteraemias in 227 patients (23.8% in those younger than 65 years; 38.3% in the 65 to 79 age group; and 37.9% in the 80 years or older group). The most common underlying disease in all the groups was diabetes mellitus. In the most elderly patients, the Charlson index was highest, there was a lower proportion of exogenous factors, and almost 25% were severely dependent (Barthel index<20). Escherichia coli was the most common germ, and the main focus was urological. The patients aged 80 years or older had predominantly healthcare-associated infections, less severe symptoms (sepsis) (66.3%) and higher mortality (29.1%) compared with the younger patients. Conclusions. The very elderly patients with bacteraemia presented fewer exogenous factors, greater comorbidity and a poorer functional situation. The most common focus was urological and the origin was healthcare related. Despite their less severe clinical presentation, these patients’ mortality was greater, and their degree of dependence was a highly relevant independent risk factor (AU)


Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Bacteriemia/clasificación , Bacteriemia/diagnóstico , Hospitales Comunitarios/normas , Hospitales Comunitarios , Factores de Riesgo , Traqueostomía/métodos , Nutrición Parenteral/métodos , Repertorio de Barthel , Estudios Prospectivos , Comorbilidad , Análisis Multivariante
4.
J Eur Acad Dermatol Venereol ; 31(2): 347-354, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27515478

RESUMEN

BACKGROUND: Onychomycosis is a common fungal nail infection that responds poorly to antifungals. OBJECTIVE: To investigate the efficacy and safety of methyl aminolevulinate (MAL) photodynamic therapy (PDT) in the treatment of onychomycosis. METHODS: A multicentre (3), randomized, placebo-controlled clinical trial compared the effects of three sessions of urea (40%) plus conventional MAL-PDT with urea (40%) plus placebo (red light) photodynamic therapy (pPDT) in onychomycosis patients. Efficacy, both clinical (onychomycosis severity index, OSI) and microbiological, was blindly evaluated after 36 weeks of follow-up. RESULTS: Forty patients were analysed in the trial. Twenty-two received MAL-PDT and 18 pPDT. A complete response (OSI = 0) was observed for four patients (18.18%) in the MAL-PDT group and one (5.56%) in the pPDT group (NTT 7.92, 95% CI: 2.98-9.69, P = 0.23). A decrease in OSI score of over 75% (OSI75) was achieved by 40.91% of the patients in the MAL-PDT group and 16.67% in the pPDT group (P = 0.096). Microbiological cure was achieved by seven patients (31.82%) in the MAL-PDT group and two (11.11%) in the pPDT group (P = 0.178). MAL-PDT resulted in better rates of clinical response [OSI >75%: 53.85% vs. 18.75% (P =0.048)] and microbiological cure [41.56% vs. 7.14% (P = 0.037)] in non-dystrophic vs. dystrophic onychomycosis patients. No significant side-effects were reported. The limitations of the study were the reduced sample size and the unexpected efficacy of the control treatment, which was attributed to the 40% urea pre-treatment. CONCLUSION: This study did not show significant differences between urea 40% + MAL-PDT and urea 40% + pPDT in the treatment of onychomycosis. However, some results suggest that this treatment may constitute an alternative for dermatophyte and non-dermatophyte mould onychomycosis in patients not eligible for systemic treatment, particularly in the absence of total nail dystrophy.


Asunto(s)
Ácido Aminolevulínico/análogos & derivados , Onicomicosis/tratamiento farmacológico , Fotoquimioterapia , Fármacos Fotosensibilizantes/uso terapéutico , Anciano , Ácido Aminolevulínico/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Placebos
5.
Rev Clin Esp (Barc) ; 217(1): 15-20, 2017.
Artículo en Inglés, Español | MEDLINE | ID: mdl-27773222

RESUMEN

OBJECTIVE: To describe the characteristics of bacteraemias, according to age, in a community hospital. MATERIAL AND METHOD: A prospective study of bacteraemias was conducted in 2011. The patients were classified into 3 age groups: younger than 65 years, 65 to 79, and 80 or older. The study collected variables on the patients and episodes. RESULTS: The study analysed 233 bacteraemias in 227 patients (23.8% in those younger than 65 years; 38.3% in the 65 to 79 age group; and 37.9% in the 80 years or older group). The most common underlying disease in all the groups was diabetes mellitus. In the most elderly patients, the Charlson index was highest, there was a lower proportion of exogenous factors, and almost 25% were severely dependent (Barthel index<20). Escherichia coli was the most common germ, and the main focus was urological. The patients aged 80 years or older had predominantly healthcare-associated infections, less severe symptoms (sepsis) (66.3%) and higher mortality (29.1%) compared with the younger patients. CONCLUSIONS: The very elderly patients with bacteraemia presented fewer exogenous factors, greater comorbidity and a poorer functional situation. The most common focus was urological and the origin was healthcare related. Despite their less severe clinical presentation, these patients' mortality was greater, and their degree of dependence was a highly relevant independent risk factor.

8.
Actas dermo-sifiliogr. (Ed. impr.) ; 106(10): 795-805, dic. 2015. ilus, tab
Artículo en Español | IBECS | ID: ibc-146615

RESUMEN

La onicomicosis, o infección fúngica de las uñas, constituye una de las enfermedades micóticas más prevalentes en la población. Su tratamiento tiene una efectividad limitada, además de ser largo y tedioso y, en el caso de los antifúngicos sistémicos, no está exento de efectos adversos. La terapia fotodinámica (TFD) podría ser una buena alternativa para las infecciones cutáneas superficiales, entre ellas la onicomicosis. El presente artículo revisa la experiencia publicada, tanto in vitro como in vivo, acerca de la utilidad de la TFD en las onicomicosis, mostrando el potencial de diversos fotosensibilizantes, así como sus limitaciones. Desde el punto de vista clínico el azul de metileno y el ácido 5-aminolevulínico muestran tasas de curación del 80% y el 43% respectivamente al año de seguimiento. Finalmente, basado en la bibliografía y en la propia experiencia, se propone un protocolo de 3 sesiones de TFD, usando metil-aminolevulinato 16% como fotosensibilizante y luz roja (lambda = 630 nm, 37J.cm−2), separadas por 1 o 2 semanas. Estas irán precedidas de la aplicación de urea 40% durante unos días. Nuevos ensayos clínicos deben optimizar los protocolos y establecer qué pacientes se benefician especialmente de recibir este tratamiento


Onychomycosis, or fungal infection of the nails, is one of the most prevalent fungal diseases in the general population. Treatment is of limited effectiveness, tedious, and must be administered for long periods. Furthermore, systemic antifungal agents are associated with adverse effects. Photodynamic therapy (PDT) may prove to be a viable alternative in the treatment of superficial skin infections, including onychomycosis. We review articles relating to the usefulness of PDT in onychomycosis in both in vitro and in vivo settings and discuss the potential and limitations of various photosensitizing agents. In vivo, methylene blue and 5-aminolevulinic acid have led to cure rates in 80% and 43% of cases, respectively, at 12 months. Finally, based on data in the literature and our own experience, we propose a protocol of 3 PDT sessions, separated by an interval of 1 or 2 weeks, using methyl aminolevulinate 16% as a photosensitizing agent and red light (Lambda = 630 nm, 37J.cm -2). Each session is preceded by the topical application of urea 40% over several days. Clinical trials are needed to optimize PDT protocols and to identify those patients who will benefit most from this treatment


Asunto(s)
Femenino , Humanos , Masculino , Onicomicosis/terapia , Fototerapia/instrumentación , Fototerapia , Ácido Aminolevulínico/uso terapéutico , 5-Aminolevulinato Sintetasa/uso terapéutico , Azul de Metileno/uso terapéutico , Fármacos Fotosensibilizantes/uso terapéutico , Onicomicosis/tratamiento farmacológico , Onicomicosis/fisiopatología , Hongos/efectos de la radiación
9.
Actas Dermosifiliogr ; 106(10): 795-805, 2015 Dec.
Artículo en Inglés, Español | MEDLINE | ID: mdl-26427737

RESUMEN

Onychomycosis, or fungal infection of the nails, is one of the most prevalent fungal diseases in the general population. Treatment is of limited effectiveness, tedious, and must be administered for long periods. Furthermore, systemic antifungal agents are associated with adverse effects. Photodynamic therapy (PDT) may prove to be a viable alternative in the treatment of superficial skin infections, including onychomycosis. We review articles relating to the usefulness of PDT in onychomycosis in both in vitro and in vivo settings and discuss the potential and limitations of various photosensitizing agents. In vivo, methylene blue and 5-aminolevulinic acid have led to cure rates in 80% and 43% of cases, respectively, at 12 months. Finally, based on data in the literature and our own experience, we propose a protocol of 3 PDT sessions, separated by an interval of 1 or 2 weeks, using methyl aminolevulinate 16% as a photosensitizing agent and red light (λ=630 nm, 37 J.cm(-2)). Each session is preceded by the topical application of urea 40% over several days. Clinical trials are needed to optimize PDT protocols and to identify those patients who will benefit most from this treatment.


Asunto(s)
Onicomicosis/tratamiento farmacológico , Fotoquimioterapia/métodos , Fármacos Fotosensibilizantes/uso terapéutico , Ácido Aminolevulínico/administración & dosificación , Ácido Aminolevulínico/análogos & derivados , Ácido Aminolevulínico/uso terapéutico , Antifúngicos/uso terapéutico , Protocolos Clínicos , Ensayos Clínicos como Asunto , Esquema de Medicación , Medicina Basada en la Evidencia , Hongos/efectos de los fármacos , Hongos/efectos de la radiación , Humanos , Azul de Metileno/administración & dosificación , Azul de Metileno/uso terapéutico , Fármacos Fotosensibilizantes/administración & dosificación , Resultado del Tratamiento , Urea/administración & dosificación , Urea/uso terapéutico
12.
Mycoses ; 57(1): 35-42, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23905682

RESUMEN

Antimicrobial photodynamic therapy (aPDT) is an emerging alternative to treat infections based on the use of photosensitisers (PSs) and visible light. To investigate the fungicidal effect of PDT against azole-resistant Candida albicans strains using two PSs with a different mechanism of action, hypericin (HYP) and 1,9-dimethyl methylene blue (DMMB), comparing their efficacy and the reactive oxygen species (ROS) species involved in their cytotoxicity. Azole-resistant and the azole-susceptible C. albicans strains were used. Solutions of 0.5 and 4 McFarland inoculum of each Candida strain were treated with different concentrations of each PS, and exposed to two light-emitting diode light fluences (18 and 37 J cm⁻²). Mechanistic insight was gained using several ROS quenchers. The minimal fungicidal concentration of HYP for ≥3 log10 CFU reduction (0.5 McFarland) was 0.62 µmol l⁻¹ for most strains, whereas for DMMB it ranged between 1.25 and 2.5 µmol l⁻¹. Increasing the fluence to 37 J cm⁻² allowed to reduce the DMMB concentration. Higher concentrations of both PSs were required to reach a 6 log10 reduction (4 McFarland). H2O2 was the main phototoxic species involved in the fungicidal effect of HYP-aPDT whereas ¹O2 was more important for DMMB-based treatments. aPDT with either HYP or DMMB is effective in killing of C. albicans strains independent of their azole resistance pattern. HYP was more efficient at low fungal concentration and DMMB at higher concentrations.


Asunto(s)
Antifúngicos/farmacología , Azoles/farmacología , Candida albicans/efectos de los fármacos , Candida albicans/efectos de la radiación , Farmacorresistencia Fúngica , Azul de Metileno/análogos & derivados , Perileno/análogos & derivados , Fármacos Fotosensibilizantes/farmacología , Antracenos , Candida albicans/crecimiento & desarrollo , Candidiasis/tratamiento farmacológico , Candidiasis/microbiología , Terapia Combinada , Humanos , Luz , Azul de Metileno/farmacología , Pruebas de Sensibilidad Microbiana , Perileno/farmacología , Fotoquimioterapia
15.
Infection ; 41(3): 701-3, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23242963

RESUMEN

We describe a case of meningitis due to Streptococcus suis with the unusual ST3 genotype. The bacterial pathogen was isolated from blood samples. S. suis genotype ST3 was initially isolated from carrier pigs, but it has not been previously associated with invasive human infections. The patient developed serious endogenous bilateral endophthalmitis which resulted in severe visual deficiency.


Asunto(s)
Meningitis Bacterianas/diagnóstico , Infecciones Estreptocócicas/diagnóstico , Streptococcus suis/clasificación , Streptococcus suis/genética , Adulto , Ceguera/diagnóstico , Ceguera/etiología , Ceguera/microbiología , Ceguera/patología , Sangre/microbiología , Endoftalmitis/complicaciones , Endoftalmitis/diagnóstico , Endoftalmitis/microbiología , Endoftalmitis/patología , Genotipo , Humanos , Masculino , Meningitis Bacterianas/complicaciones , Meningitis Bacterianas/microbiología , Meningitis Bacterianas/patología , Tipificación Molecular , Infecciones Estreptocócicas/complicaciones , Infecciones Estreptocócicas/microbiología , Infecciones Estreptocócicas/patología , Streptococcus suis/aislamiento & purificación
16.
Eur J Clin Microbiol Infect Dis ; 31(3): 257-60, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21626450

RESUMEN

Thirteen vancomycin-resistant and teicoplanin-susceptible Enterococcus faecalis isolates were recovered from unrelated patients in three Spanish hospitals from November 2009 to December 2010. All isolates carried the vanB2 gene, showed indistinguishable or closely-related PFGE patterns and were ascribed to the sequence type ST6 (included into the high-risk clonal-complex CC2). They showed a multiresistance phenotype (erythromycin, tetracycline, ciprofloxacin and high-level-resistance to streptomycin, gentamicin and kanamycin) and harboured the aac(6')-aph(2"), ant(6)-Ia, and tet(M)+/-tet(L) genes. All isolates produced gelatinase and harboured the gelE gene, but not the esp or hyl genes. The inclusion of the vanB2 gene into the Tn5382 transposon was demonstrated in one isolate. Clonal dissemination of vanB2-containing the E. faecalis strain is demonstrated.


Asunto(s)
Proteínas Bacterianas/genética , Farmacorresistencia Bacteriana Múltiple/genética , Enterococcus faecalis/genética , Resistencia a la Vancomicina/genética , Anciano , Anciano de 80 o más Años , Enterococcus faecalis/aislamiento & purificación , Femenino , Gelatinasas/metabolismo , Infecciones por Bacterias Grampositivas/epidemiología , Infecciones por Bacterias Grampositivas/genética , Infecciones por Bacterias Grampositivas/microbiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , España/epidemiología , Infecciones Urinarias/microbiología
17.
Clin Microbiol Infect ; 17(6): 923-7, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21682806

RESUMEN

Skin infection associated with methicillin-resistant Staphylococcus aureus (MRSA)-ST398 was detected in a pig-farmer, and MRSA-ST398 isolates were also detected in nasal samples of the patient and of 11/12 pigs on his farm. Twelve MRSA isolates were obtained from skin lesions (n = 6) and nasal samples (n = 6) of the patient in two sampling moments and 11 MRSA isolates from nasal samples of pigs. They were typed as t011-SCCmecIVa-agrI and t108-SCCmecV-agrI (patient and pigs) and t588-SCCmecV-agrI (patient). The following resistance genes were detected (number isolates): tet(K) (1), tet(L) (23), tet(M) (13), erm(A) (13), erm(C) (13), msr(A) (11), lnu(A) (21), aph(2'')-acc(6') (3), ant(4') (13), aph(3') (12), dfrS1 (15) and dfrK (22). Seventeen human and animal MRSA-ST398 isolates showed indistinguishable PFGE patterns (A1-spa-t011 or B2-spa-t108) and similar phenotypic-genotypic characteristics, including the presence of the lnu(A) gene, associated with lincomycin resistance. Potential pig-to-human transference of ST398 is suggested in this study. The first detection of the lnu(A) gene in MRSA-ST398 is reported.


Asunto(s)
Staphylococcus aureus Resistente a Meticilina/clasificación , Staphylococcus aureus Resistente a Meticilina/aislamiento & purificación , Infecciones Cutáneas Estafilocócicas/diagnóstico , Infecciones Cutáneas Estafilocócicas/microbiología , Porcinos/microbiología , Zoonosis/microbiología , Zoonosis/transmisión , Agricultura , Animales , Técnicas de Tipificación Bacteriana , Portador Sano/microbiología , Portador Sano/veterinaria , Análisis por Conglomerados , Electroforesis en Gel de Campo Pulsado , Genes Bacterianos , Genotipo , Humanos , Masculino , Staphylococcus aureus Resistente a Meticilina/genética , Persona de Mediana Edad , Epidemiología Molecular , Tipificación Molecular , Mucosa Nasal/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...